DE:NYZ Stock Latest News
Company AnnouncementsNovacyt Announces Australian Approval for Yourgene Insight DPYD Test1w ago
Company AnnouncementsNovacyt Reports October Liquidity Activity and Voting Rights2w ago
Company AnnouncementsNovacyt S.A. Earnings Call Signals Cost-Driven Shift1M ago
Company AnnouncementsNovacyt Updates Liquidity Agreement Trades and Voting Rights Base1M ago
Company AnnouncementsNovacyt lifts H1 revenue on diagnostics growth and Asia-Pacific deal1M ago
Company AnnouncementsNovacyt sets date for interim results and investor webinar as it highlights global diagnostics reach1M agoCompany AnnouncementsNovacyt Gains IVDR Certification for Comprehensive DPYD Pharmacogenomic Assay2M ago
Company AnnouncementsNovacyt updates market on liquidity agreement activity and total voting rights2M ago
Company AnnouncementsNovacyt strikes five-year collaboration framework with Illumina2M ago
Company AnnouncementsNovacyt Updates Liquidity Agreement Activity and Confirms Total Voting Rights3M ago
Company AnnouncementsNovacyt lifts first-half revenue as restructuring and Southern Cross deal reshape growth profile3M ago
Company AnnouncementsNovacyt Updates Market on Liquidity Agreement and Voting Rights4M ago
Company AnnouncementsNovacyt wins shareholder backing for growth-focused AGM resolutions4M ago
Company AnnouncementsNovacyt Updates Market on Liquidity Agreement Trades and Voting Rights5M ago
Company AnnouncementsNovacyt Plans Major Headcount Cut to Slash Cash Burn After Expansion Drive5M ago
Company AnnouncementsNovacyt sets June date for in-person AGM and online investor presentation6M ago
Company AnnouncementsNovacyt launches enhanced DPYD assay to boost safety of chemotherapy6M ago
Company AnnouncementsNovacyt announces immediate departure of Chief Scientific Officer6M ago


